This is the fourth vaccine created in the US, developed according to the traditional protein-based methodology, which distinguishes it from mRNA vaccines. Centers for Disease Control and Prevention consultants have unanimously voted to use Novavax's NVAX.O COVID-19 vaccine and recommend it to individuals over 18 years of age. The vaccine has already been approved by the Immunization Practices Advisory Committee, whose director Rochelle Walensky has yet to sign the recommendations…